Question

1. Treatment, such as ___________, can be used to reduce spasticity in individuals with cerebral palsy. (click all that apply)

a.) Anticonvulsant medication

b.) Stretching exercise

c.) Botulinum toxin

d.) Orthopedic surgery

2. What is true about Chronic obstructive pulmonary disease patients?

a.) Functional capacity (depicted by 12 min Walk) was significantly improved in SPEED training group only compared to O2 cart pushing group.

b.) Muscular strength was improved significantly in the SPEED group only compared to O2 cart pushing group in COPD patients.

3. What is the typical characteristic of patients at moderate risk for exercise participation (from the risk stratification criteria for patients with cardiovascular disease)?

a.) Absence of complicated ventricular dysrhythmias at rest.

b.) Presence of abnormal hemodynamics with exercise testing (e.g., severe postexercise hypotension)

c.) High level of silent ischemia during exercise testing

d.) Functional capacity <5 METs with exercise testing

4. For in patient with coronary artery disease and myocardial infarction, the aerobic exercise intensity can be set as RPE ______ on 6-20 scale, and for post surgery as resting HR +____.

a.) ≤11, +30 bpm

b.) ≤11, +20 bpm

c.) ≤13, +30 bpm

Answer 1

1. Answer- a, c and d

Explanation- The treatment options for management of spasticity in children with cerebral palsy include oral medications( Anticonvulsants), physical and occupational therapy, splinting and casting, chemodenervation with botulinum toxin or phenol, selective dorsal rhizotomy, baclofen pump (to help control muscle spasticity) and orthopedic surgery specially Spine or spinal cord surgery (to repair scoliosis or reduce spasticity).

Hope this helps you. Thank you ?